Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells

Bai,Ying; Qiu,Guang-Rong; Zhou,Fan; Gong,Li-Ying; Gao,Feng; Sun,Kai-Lai

doi:10.3892/ijo.2013.1831

Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells

Authors:
- Ying Bai
- Guang-Rong Qiu
- Fan Zhou
- Li-Ying Gong
- Feng Gao
- Kai-Lai Sun
View Affiliations

Affiliations: Department of Hematology, Shenyang General Military Hospital, Shenyang, P.R. China, Department of Medical Genetics, China Medical University, Shenyang, P.R. China
Published online on: February 19, 2013 https://doi.org/10.3892/ijo.2013.1831
Pages: 1317-1324

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dicer, a member of the RNase III family, is the key enzyme required for the biogenesis of microRNAs and small interfering RNAs. Recent evidence indicates that DICER1 expression levels vary among different solid tumors and decreased or increased DICER1 expression has been associated with aggressive cancers. In this study, we assessed DICER1 expression levels in acute myeloid leukemia (AML) and investigated its biological effects and transcriptional regulation in leukemia cell lines. We demonstrated that DICER1 was overexpressed in AML patients and leukemia cell lines by real-time quantitative PCR and western blot analysis. A functional assay demonstrated that the silencing of DICER1 inhibited cell proliferation and promoted apoptosis in leukemia cell lines. We also demonstrated that DICER1 was upregulated by the hematopoietic transcription factor, GATA1, through luciferase, electrophoretic mobility shift and chromatin immunoprecipitation assays. These data suggest that DICER1 plays an important role in AML and the finding that the upregulation of DICER1 is induced by GATA1 may provide a framework for the understanding of differential DICER1 expression levels in multiple types of cancer.

View Figures

View References

1	Cerutti H and Casas-Mollano JA: On the origin and functions of RNA-mediated silencing: from protists to man. Curr Genet. 50:81–99. 2006. View Article : Google Scholar : PubMed/NCBI
2	Peng JJ, Yan F, Chen HR and Chen JP: Progress of studies on Dicer structure and function. Yi Chuan. 30:1550–1556. 2008.(In Chinese).
3	Lee YS, Nakahara K, Pham JW, et al: Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell. 117:69–81. 2004.
4	Filipowicz W, Jaskiewicz L, Kolb FA and Pillai RS: Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol. 15:331–341. 2005. View Article : Google Scholar : PubMed/NCBI
5	Chiosea S, Jelezcova E, Chandran U, et al: Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 169:1812–1820. 2006. View Article : Google Scholar : PubMed/NCBI
6	Chiosea S, Jelezcova E, Chandran U, et al: Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67:2345–2350. 2007. View Article : Google Scholar : PubMed/NCBI
7	Merritt WM, Lin YG, Han LY, et al: Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
8	Karube Y, Tanaka H, Osada H, et al: Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
9	Grelier G, Voirin N, Ay AS, et al: Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer. 101:673–683. 2009. View Article : Google Scholar : PubMed/NCBI
10	Zighelboim I, Reinhart AJ, Gao F, et al: DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma. Cancer. 117:1446–1453. 2011. View Article : Google Scholar : PubMed/NCBI
11	Faber C, Horst D, Hlubek F and Kirchner T: Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer. 47:1414–1419. 2011. View Article : Google Scholar : PubMed/NCBI
12	Vaksman O, Hetland TE, Trope’ CG, et al: Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Hum Pathol. 43:2062–2069. 2012. View Article : Google Scholar : PubMed/NCBI
13	Ross J, Bottardi S, Bourgoin V, Wollenschlaeger A, Drobetsky E, et al: Differential requirement of a distal regulatory region for pre-initiation complex formation at globin gene promoters. Nucleic Acids Res. 37:5295–5308. 2009. View Article : Google Scholar : PubMed/NCBI
14	Li J, Wang E, Dutta S, Lau JS, Jiang SW, et al: Protein kinase C-mediated modulation of FIH-1 expression by the home-odomain protein CDP/Cut/Cux. Mol Cell Biol. 27:7345–7353. 2007. View Article : Google Scholar : PubMed/NCBI
15	Harigae H: GATA transcription factors and hematological diseases. Tohoku J Exp Med. 210:1–9. 2006. View Article : Google Scholar : PubMed/NCBI
16	Shimizu R and Yamamoto M: Function and gene expression regulation of GATA-1 and GATA-2 transcription. Seikagaku. 79:941–952. 2007.(In Japanese).
17	Shimamoto T, Ohyashiki JH, Ohyashiki K, et al: GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia. Leukemia. 8:1176–1180. 1994.PubMed/NCBI
18	Guerrasio A, Saglio G, Rosso C, et al: Expression of GATA-1 mRNA in human myeloid leukemic cells. Leukemia. 8:1034–1038. 1994.PubMed/NCBI
19	Shimamoto T, Ohyashiki K, Ohyashiki JH, et al: The expression pattern of erythrocyte/megakaryocytes-related transcription factors GATA-1 and stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood. 86:3173–3180. 1995.
20	Ayala RM, Martínez-López J, Albízua E, et al: Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol. 84:79–86. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ohyashiki K, Ohyashiki JH, Shimamoto T and Toyama K: Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes. Leuk Lymphoma. 23:431–436. 1996. View Article : Google Scholar : PubMed/NCBI
22	Papachristou DJ, Korpetinou A, Giannopoulou E, et al: Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch. 459:431–440. 2011. View Article : Google Scholar : PubMed/NCBI
23	Zhou Y, Chen L, Barlogie B, Stephens O, Wu X, Williams DR, et al: High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl Acad Sci USA. 107:7904–7909. 2010. View Article : Google Scholar : PubMed/NCBI
24	Jakymiw A, Patel RS, Deming N, et al: Overexpression of Dicer as a result of reduced let-7 microRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer. 49:549–559. 2010. View Article : Google Scholar : PubMed/NCBI
25	Wiesen JL and Tomasi TB: Dicer is regulated by cellular stresses and interferons. Mol Immunol. 46:1222–1228. 2009. View Article : Google Scholar : PubMed/NCBI
26	Levy C, Khaled M, Robinson KC, et al: Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell. 141:994–1005. 2010. View Article : Google Scholar : PubMed/NCBI